NEWS On the Health Affairs Blog: Hwang and Kesselheim Analyze the Impact of Taxing Drug Price Spikes 5/12/17

In the latest post on the IVI-sponsored Health Affairs blog series, Thomas Hwang and Aaron Kesselheim examine proposed new legislation taxing manufacturers of pharmaceuticals with medications exhibiting significant pricing spikes. Hwang and Kesselheim break down the criteria for the tax, and also offer some insight into potential policy implications.

Read more here.